Overview
Oxalobacter formigenes is a strictly anaerobic, Gram-negative bacterium belonging to the family Oxalobacteraceae within the phylum Pseudomonadota (formerly Proteobacteria). It is unique among human gut bacteria as an obligate oxalotroph, meaning that oxalate is its sole energy and carbon source. This specialized metabolism positions O. formigenes as a critical organism in the gut-kidney axis, where it degrades dietary oxalate before it can be absorbed into the bloodstream and excreted by the kidneys, potentially preventing calcium oxalate kidney stone formation.
Classification
O. formigenes belongs to the order Burkholderiales within the class Betaproteobacteria. It is the best-characterized species in the genus Oxalobacter and occupies a highly specialized ecological niche in the gut that depends on the availability of dietary oxalate. Unlike most gut commensals that can utilize multiple substrates, O. formigenes requires oxalate for survival, making it uniquely vulnerable to disruption by antibiotics and dietary changes. Its presence or absence in the gut microbiome has direct implications for oxalate homeostasis and kidney health.
Key Characteristics
O. formigenes utilizes two key enzymes — oxalate decarboxylase and formyl-CoA transferase — to catabolize oxalate, converting it to formate and carbon dioxide. This degradation occurs in the intestinal lumen before oxalate can be absorbed systemically. The bacterium's colonization capacity has been demonstrated in human volunteers, where single oral ingestion successfully established gut colonization and reduced urinary oxalate excretion following dietary oxalate loading. Colonization efficacy appears to correlate with baseline oxalate-degrading gene abundance (oxc, frc genes) rather than dose or strain characteristics.
Health Significance
The absence of O. formigenes from the gut microbiome is strongly linked to increased risk of calcium oxalate kidney stone recurrence. Research has identified antibiotic susceptibility as the primary reason for its disappearance from the gut, with cystic fibrosis patients (who receive frequent antibiotic courses) being notably deficient in this organism and at elevated risk for hyperoxaluria. Clinical colonization studies have demonstrated that inducing O. formigenes colonization in adults with a history of calcium oxalate stones may reduce urinary oxalate excretion to a statistically significant degree. These findings suggest that O. formigenes supplementation or preservation strategies could serve as a targeted approach to kidney stone prevention, though widespread clinical application will require further validation of colonization protocols and long-term efficacy.